Details for Patent: 9,463,289
✉ Email this page to a colleague
Which drugs does patent 9,463,289 protect, and when does it expire?
Patent 9,463,289 protects PROAIR HFA, QVAR 40, and QVAR 80, and is included in two NDAs.
This patent has one hundred and ninety-two patent family members in twenty-four countries.
Summary for Patent: 9,463,289
Title: | Dose counters for inhalers, inhalers and methods of assembly thereof |
Abstract: | A manually operated metered dose inhaler includes a dose counter chamber including a dose display tape driven by a ratchet wheel which is driven in turn by an actuator pawl actuated by movement of a canister, the tape unwinding from a stock bobbin during use of the inhaler, a rotation regulator being provided for the stock bobbin and including a wavelike engagement surface with concavities which engage against control elements in the form of protrusions on resilient forks of a split pin thereby permitting incremental unwinding of the stock bobbin yet resisting excessive rotation if the inhaler is dropped onto a hard surface. |
Inventor(s): | Walsh; Declan (County Kilkenny, IE), Fenlon; Derek (County Wexford, IE), Kaar; Simon (County Cork, IE), Hazenberg; Jan Geert (County Kilkenny, IE), Buck; Daniel (County Waterford, IE), Clancy; Paul (Waterford, IE), Uschold; Robert Charles (Leominster, MA), Karg; Jeffrey A. (Hopkinton, MA) |
Assignee: | IVAX Pharmaceuticals Ireland (Waterford, IE) Norton (Waterford) Limited (Waterford, IE) Teva Pharmaceuticals Ireland (Waterford, IE) |
Application Number: | 14/103,324 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,463,289 |
Patent Claim Types: see list of patent claims | Delivery; |
Drugs Protected by US Patent 9,463,289
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | PROAIR HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 021457-001 | Oct 29, 2004 | AB2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Teva Branded Pharm | QVAR 40 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-002 | Sep 15, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,463,289
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011254958 | ⤷ Try a Trial | |||
Brazil | 112012029106 | ⤷ Try a Trial | |||
Canada | 2799625 | ⤷ Try a Trial | |||
Canada | 2887315 | ⤷ Try a Trial | |||
Canada | 2936362 | ⤷ Try a Trial | |||
Canada | 3019694 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |